Loading...
XNYSATR
Market cap10bUSD
Jan 03, Last price  
155.50USD
1D
0.87%
1Q
-3.16%
Jan 2017
111.71%
Name

Aptargroup Inc

Chart & Performance

D1W1MN
XNYS:ATR chart
P/E
36.37
P/S
2.97
EPS
4.28
Div Yield, %
1.00%
Shrs. gr., 5y
0.59%
Rev. gr., 5y
4.75%
Revenues
3.49b
+4.97%
1,296,608,0001,380,009,0001,601,385,0001,892,167,0002,071,685,0001,841,616,0002,076,719,0002,337,183,0002,331,036,0002,520,013,0002,597,809,0002,317,149,0002,330,934,0002,469,283,0002,764,761,0002,859,732,0002,929,340,0003,227,221,0003,322,249,0003,487,450,000
Net income
284m
+18.89%
93,287,000100,034,000102,896,000141,739,000153,495,000124,623,000173,481,000183,683,000162,612,000171,994,000191,658,000199,348,000205,590,000220,030,000194,745,000242,202,000214,040,000244,097,000239,288,000284,487,000
CFO
575m
+20.19%
183,225,000194,055,000197,461,000273,463,000270,211,000293,591,000261,715,000261,042,000313,892,000285,436,000314,551,000324,515,000327,193,000324,729,000313,628,000514,457,000570,153,000363,443,000478,617,000575,239,000
Dividend
Jul 25, 20240.45 USD/sh
Earnings
Feb 06, 2025

Profile

AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. It sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. The company has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
URL
https://www.aptar.com/
IPO date
Apr 23, 1993
Employees
13,500
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
3,487,450
4.97%
3,322,249
2.94%
Cost of revenue
2,789,834
2,702,673
Unusual Expense (Income)
NOPBT
697,616
619,576
NOPBT Margin
20.00%
18.65%
Operating Taxes
90,649
95,149
Tax Rate
12.99%
15.36%
NOPAT
606,967
524,427
Net income
284,487
18.89%
239,288
-1.97%
Dividends
(103,683)
(99,461)
Dividend yield
1.25%
1.36%
Proceeds from repurchase of equity
(47,552)
(63,614)
BB yield
0.57%
0.87%
Debt
Debt current
458,220
122,791
Long-term debt
748,835
1,095,545
Deferred revenue
22,887
25,361
Other long-term liabilities
156,699
119,557
Net debt
934,209
1,024,296
Cash flow
Cash from operating activities
575,239
478,617
CAPEX
(318,403)
(315,616)
Cash from investing activities
(324,463)
(295,642)
Cash from financing activities
(171,554)
(162,096)
FCF
375,121
504,144
Balance
Cash
223,643
141,732
Long term investments
49,203
52,308
Excess cash
98,474
27,928
Stockholders' equity
1,816,273
1,602,852
Invested Capital
3,541,312
3,360,582
ROIC
17.59%
15.52%
ROCE
19.07%
18.17%
EV
Common stock shares outstanding
66,905
66,719
Price
123.62
12.40%
109.98
-10.21%
Market cap
8,270,796
12.72%
7,337,756
-11.48%
EV
9,219,479
8,376,321
EBITDA
946,209
853,282
EV/EBITDA
9.74
9.82
Interest
40,418
40,827
Interest/NOPBT
5.79%
6.59%